Correlation Between Takeda Pharmaceutical and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Sunshine Biopharma, you can compare the effects of market volatilities on Takeda Pharmaceutical and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Sunshine Biopharma.
Diversification Opportunities for Takeda Pharmaceutical and Sunshine Biopharma
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Takeda and Sunshine is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Sunshine Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Sunshine Biopharma
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.05 times more return on investment than Sunshine Biopharma. However, Takeda Pharmaceutical Co is 19.47 times less risky than Sunshine Biopharma. It trades about -0.12 of its potential returns per unit of risk. Sunshine Biopharma is currently generating about -0.07 per unit of risk. If you would invest 1,418 in Takeda Pharmaceutical Co on March 2, 2024 and sell it today you would lose (115.00) from holding Takeda Pharmaceutical Co or give up 8.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 96.88% |
Values | Daily Returns |
Takeda Pharmaceutical Co vs. Sunshine Biopharma
Performance |
Timeline |
Takeda Pharmaceutical |
Sunshine Biopharma |
Takeda Pharmaceutical and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Takeda Pharmaceutical and Sunshine Biopharma
The main advantage of trading using opposite Takeda Pharmaceutical and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.Takeda Pharmaceutical vs. Halo Collective | Takeda Pharmaceutical vs. China SXT Pharmaceuticals | Takeda Pharmaceutical vs. Petros Pharmaceuticals | Takeda Pharmaceutical vs. SNDL Inc |
Sunshine Biopharma vs. Halo Collective | Sunshine Biopharma vs. China SXT Pharmaceuticals | Sunshine Biopharma vs. Petros Pharmaceuticals | Sunshine Biopharma vs. SNDL Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |